Rebounding from their 11.8% decline last week, shares of Tempus AI (NASDAQ: TEM) are starting June on an auspicious note. In ...

TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...

Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

Tempus AI, SoundHound AI, and Innodata post surging growth, offering overlooked exposure to the booming AI trend.

Based on its analysis, Spruce Point stated that Tempus AI stock has the potential to fall about 50% to 60%. From the stock's ...

An investment management firm known for short-selling the stocks it speaks against is now targeting a high-risk, high-reward ...

Spruce Point Capital Management has announced a new short position against Tempus AI Inc (NASDAQ:TEM). The short seller on ...

Spruce Point's short report sent Tempus AI stock down 20%. TEM shares were overvalued and risky to own even without the short ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top-performing stocks on Monday. Tempus AI extended its winning streak to a third ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...

Dave Ramsey Says "Take Social Security at 62" - Here's When That's Actually Brilliant Advice ...

Spruce Point said Tempus’ revenue quality should be carefully scrutinized, because of signs of "aggressive accounting." ...